Wall Street’s Next Goldmine: Why Baldness Drugs Will Beat GLP-1 Stocks
New treatments for pattern hair loss are driving a surge in biotech stock valuations as Wall Street targets the condition as an untapped consumer market. How New Hair Loss Drug Stocks Are Surging The promise of novel treatments has driven substantial market gains for pharmaceutical developers. Meanwhile, Absci stock has more than doubled throughout the … Read more